BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9176040)

  • 1. Effect of urodilatin infusion on renal haemodynamics, tubular function and vasoactive hormones.
    Carstens J; Jensen KT; Pedersen EB
    Clin Sci (Lond); 1997 Apr; 92(4):397-407. PubMed ID: 9176040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and action of urodilatin infusion in healthy volunteers.
    Carstens J; Jensen KT; Pedersen EB
    Clin Pharmacol Ther; 1998 Jul; 64(1):73-86. PubMed ID: 9695722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of a urodilatin infusion in patients with liver cirrhosis, with and without ascites.
    Carstens J; Greisen J; Jensen KT; Vilstrup H; Pedersen EB
    J Am Soc Nephrol; 1998 Aug; 9(8):1489-98. PubMed ID: 9697672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
    Carstens J; Pedersen EB
    Scand J Clin Lab Invest; 2008; 68(1):2-10. PubMed ID: 17852806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.
    Eiskjaer H; Nielsen CB; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1996 Jul; 26(7):584-95. PubMed ID: 8864421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of continuous urodilatin infusion: a dose-finding study.
    Dorner GT; Selenko N; Kral T; Schmetterer L; Eichler HG; Wolzt M
    Clin Pharmacol Ther; 1998 Sep; 64(3):322-30. PubMed ID: 9757156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
    Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular, endocrine, and renal effects of urodilatin in normal humans.
    Bestle MH; Olsen NV; Christensen P; Jensen BV; Bie P
    Am J Physiol; 1999 Mar; 276(3):R684-95. PubMed ID: 10070128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
    Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site of the action of a synthetic atrial natriuretic peptide evaluated in humans.
    Biollaz J; Bidiville J; Diézi J; Waeber B; Nussberger J; Brunner-Ferber F; Gomez HJ; Brunner HR
    Kidney Int; 1987 Oct; 32(4):537-46. PubMed ID: 2963166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
    Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
    Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine natriuresis in salt-repleted, water-loaded humans: a dose-response study.
    Olsen NV; Olsen MH; Bonde J; Kanstrup IL; Plum I; Strandgaard S; Leyssac PP
    Br J Clin Pharmacol; 1997 May; 43(5):509-20. PubMed ID: 9159566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs.
    Bestle MH; Bie P
    Acta Physiol Scand; 1993 Sep; 149(1):77-83. PubMed ID: 8237425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention.
    Carstens J; Grønbaek H; Larsen HK; Pedersen EB; Vilstrup H
    BMC Gastroenterol; 2007 Jan; 7():1. PubMed ID: 17257428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal action of atrial natriuretic peptide during control of glomerular filtration.
    Burnett JC; Opgenorth TJ; Granger JP
    Kidney Int; 1986 Jul; 30(1):16-9. PubMed ID: 2943930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephron sites of the natriuretic effect of intrarenal infusion of atrial natriuretic peptide in the rat.
    Ader JL; Tran-Van T; Praddaude F
    Am J Hypertens; 1990 Nov; 3(11):870-2. PubMed ID: 2148093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.